Skip to main content
MSLE
NASDAQ Life Sciences

FDA Grants Fast Track to Satellos' SAT-3247 for Duchenne Muscular Dystrophy

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$7.5
Mkt Cap
$147.485M
52W Low
$5.44
52W High
$144
52W Position info
38% above low
Off High info
95% below high
Rel. Volume info
0.6× avg
Market data snapshot near publication time

MSLE sits 38% above its 52-week low of $5.44.

Summary

Satellos Bioscience's drug candidate, SAT-3247, has received FDA Fast Track designation for Duchenne Muscular Dystrophy. This regulatory milestone, also disclosed in a 6-K filing today, is highly positive for the clinical-stage biotech. Fast Track status facilitates expedited development and review, offering more frequent FDA interactions and potential eligibility for Accelerated Approval. This significantly de-risks the program and validates SAT-3247's potential to address an unmet medical need. The company is currently progressing SAT-3247 through its Phase 2 BASECAMP and TRAILHEAD studies.

At the time of this announcement, MSLE was trading at $7.50 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $147.5M. The 52-week trading range was $5.44 to $144.00. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

MSLE - Latest Insights

MSLE
Nov 12, 2026, 7:00 AM EST
Filing Type: 6-K
Importance Score:
7
Price at Filing: $6.88
Real-time Price: $6.63 info
Change: -$0.255 (-4%) info
Market Cap: $140.559M info
MSLE
Nov 06, 2026, 7:00 AM EST
Filing Type: 6-K
Importance Score:
8
Price at Filing: $6.00
Real-time Price: $6.63 info
Change: +$0.625 (+10%) info
Market Cap: $140.559M info
MSLE
Sep 30, 2026, 7:00 AM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $8.60
Real-time Price: $6.63 info
Change: -$1.97 (-23%) info
Market Cap: $140.559M info
MSLE
Sep 24, 2026, 7:00 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $8.91
Real-time Price: $6.63 info
Change: -$2.29 (-26%) info
Market Cap: $140.559M info
MSLE
Aug 13, 2026, 5:03 PM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $9.82
Real-time Price: $6.63 info
Change: -$3.20 (-33%) info
Market Cap: $140.559M info